← Back to Clinical Trials
Recruiting NCT07030998

NCT07030998 Wearable Technology and Machine Learning for Early Detection and Risk Assessment of Unacceptable Toxicities in a Paediatric Oncology Cohort

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07030998
Status Recruiting
Phase
Sponsor Murdoch Childrens Research Institute
Condition Cancer
Study Type OBSERVATIONAL
Enrollment 150 participants
Start Date 2025-10-15
Primary Completion 2027-08

Eligibility & Interventions

Sex All sexes
Min Age 5 Years
Max Age 18 Years
Study Type OBSERVATIONAL
Interventions
Wearable Device

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 150 participants in total. It began in 2025-10-15 with a primary completion date of 2027-08.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Data collection study to establish a predictive model of infection observed during childhood cancer therapy using data captured by wearable technology.

Eligibility Criteria

Inclusion Criteria: * Paediatric, adolescent or young adult diagnosis of cancer AND receiving therapy placing them at risk of infection * Receiving cancer treatment at The Royal Children's Hospital * Patients aged 5-18 years at time of the eligibility screening * If aged \< 16 years, parent or guardian able to provide consent * iPhone 8 or later (iOS must be up to date/updated at time of enrolment) * At least 10MB of iPhone storage for WEARABLES app and data collection. * Willing and able to wear a wearable device for a period of 4 weeks (during waking hours). * Consent to data being shared to the WEARABLES app (owned by the research team). Exclusion Criteria: * \<5 years of age. * \<16 years of age without guardian or parent consent. * Aged 16-18 and unable to provide consent. * Participant did not consent to wearing Apple Watch for a period of 4 weeks.

Contact & Investigator

Central Contact

Lane Collier

✉ lane.collier@mcri.edu.au

📞 03 9936 6324

Frequently Asked Questions

Who can join the NCT07030998 clinical trial?

This trial is open to participants of all sexes, aged 5 Years or older, up to 18 Years, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07030998 currently recruiting?

Yes, NCT07030998 is actively recruiting participants. Contact the research team at lane.collier@mcri.edu.au for enrollment information.

Where is the NCT07030998 trial being conducted?

This trial is being conducted at Parkville, Australia.

Who is sponsoring the NCT07030998 clinical trial?

NCT07030998 is sponsored by Murdoch Childrens Research Institute. The trial plans to enroll 150 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology